Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text Full Text (PDF, 4227K) PPT slides of all figures Supplemental Material Index Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JCB Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Jablonka, S. Articles by Sendtner, M. Search for Related Content PubMed PubMed Citation Articles by Jablonka, S. Articles by Sendtner, M. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Compound via MeSH Substance via MeSH Medline Plus Health Information Spinal Muscular Atrophy Related Collections Related Article Social Bookmarking                      What's this?

Institute for Clinical Neurobiology, University of Wuerzburg, Wuerzburg D-97078, Germany

Correspondence to Michael Sendtner: Sendtner_M{at}klinik.uni-wuerzburg.de

Proximal spinal muscular atrophy (SMA) is a motoneuron disease for which there is currently no effective treatment. In animal models of SMA, spinal motoneurons exhibit reduced axon elongation and growth cone size. These defects correlate with reduced ß-actin messenger RNA and protein levels in distal axons. We show that survival motoneuron gene (Smn)–deficient motoneurons exhibit severe defects in clustering Ca_v2.2 channels in axonal growth cones. These defects also correlate with a reduced frequency of local Ca²⁺ transients. In contrast, global spontaneous excitability measured in cell bodies and proximal axons is not reduced. Stimulation of Smn production from the transgenic SMN2 gene by cyclic adenosine monophosphate restores Ca_v2.2 accumulation and excitability. This may lead to the development of new therapies for SMA that are not focused on enhancing motoneuron survival but instead investigate restoration of growth cone excitability and function.

S. Jablonka and M. Beck contributed equally to this paper.

Abbreviations used in this paper: 8-CPT-cAMP, 8-(4-chlorophenylthio)–3',5' cAMP; ANOVA, analysis of variance; CTX, -conotoxin MVIIA; E, embryonic day; NMJ, neuromuscular junction; SMA, spinal muscular atrophy; Smn, survival motoneuron gene; STED, stimulated emission depletion; TRPC, transient receptor potential ion channel; TTX, tetrodotoxin; VGCC, voltage-gated Ca²⁺ channel.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Related Article

Calcium channels SMA

Ruth Williams
J. Cell Biol. 2007 179: 3. [Full Text] [PDF]

This article has been cited by other articles:

• Ferron, L., Davies, A., Page, K. M., Cox, D. J., Leroy, J., Waithe, D., Butcher, A. J., Sellaturay, P., Bolsover, S., Pratt, W. S., Moss, F. J., Dolphin, A. C. (2008). The Stargazin-Related Protein {gamma}7 Interacts with the mRNA-Binding Protein Heterogeneous Nuclear Ribonucleoprotein A2 and Regulates the Stability of Specific mRNAs, Including CaV2.2. J. Neurosci. 28: 10604-10617 [Abstract] [Full Text]  
• Kariya, S., Park, G.-H., Maeno-Hikichi, Y., Leykekhman, O., Lutz, C., Arkovitz, M. S., Landmesser, L. T., Monani, U. R. (2008). Reduced SMN protein impairs maturation of the neuromuscular junctions in mouse models of spinal muscular atrophy. Hum Mol Genet 17: 2552-2569 [Abstract] [Full Text]  
• Oprea, G. E., Krober, S., McWhorter, M. L., Rossoll, W., Muller, S., Krawczak, M., Bassell, G. J., Beattie, C. E., Wirth, B. (2008). Plastin 3 Is a Protective Modifier of Autosomal Recessive Spinal Muscular Atrophy. Science 320: 524-527 [Abstract] [Full Text]  
• Williams, R. (2007). Calcium channels SMA. JCB 179: 3-3 [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents